MSC-11-FCD

N/A

Report date: 2023/01/12 15:46:42

Base Information

Drug NameMSC-11-FCD
Drug Alias NameMesenchymal stem cells into which the suicide gene, cytosine deaminase (CD)MSC-11-FCD
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsBrain NeoplasmsGliosarcomaGlioblastoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCha University
China Registration ClassN/A

Develop Information

Active CompaniesCha University
Inactive CompaniesN/A
Active IndicationsBrain NeoplasmsGliosarcomaGlioblastoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A